Verteporfin-loaded hydrogel targeting YAP-mediated MDSCs recruitment for the treatment of residual tumors after incomplete radiofrequency ablation. [PDF]
Chen J +8 more
europepmc +1 more source
Modulatory Effects of Bioactive Phytoconstituents on the Amplitude and Gating Properties of Membrane Ion Channels. [PDF]
Wu SN +3 more
europepmc +1 more source
Lysophosphatidic acid mediates skeletal muscle fibrosis in denervation via activation of YAP/TAZ. [PDF]
Cruz-Soca M +14 more
europepmc +1 more source
ID1 promotes the progression of esophageal cancer via modulating PTEN/YAP/galectin-3 signaling pathway induced proliferation and immune suppression. [PDF]
Ji Y, Yan Z, Gao Z, Li W, Xu X.
europepmc +1 more source
Targeting the Hippo pathway in pulmonary arterial hypertension: emerging pharmacological strategies. [PDF]
Zheng D, Guo Y.
europepmc +1 more source
Beyond Treatment: The Strategy of Nonintervention in Choroidal Hemangioma. [PDF]
Khan H +8 more
europepmc +1 more source
Subclonal β-catenin/YAP signaling heterogeneity accelerates ovarian cancer metastasis through a senescence-associated secretory phenotype. [PDF]
To SKY +7 more
europepmc +1 more source
Verteporfin inhibits the cGAS-STING pathway and improves the tumor microenvironment during cisplatin treatment in hepatocellular carcinoma. [PDF]
Gong Y +10 more
europepmc +1 more source
HDAC4/MybL1/YAP novel signaling axis is required for pancreatic cancer metastasis to the liver. [PDF]
Edderkaoui M +14 more
europepmc +1 more source
TRIM16 mediates YAP1 K63-linked ubiquitination to alleviate sepsis-induced acute liver injury through YAP/Nrf2 axis in mice. [PDF]
Zhang K +8 more
europepmc +1 more source

